Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 864 for:    LENALIDOMIDE AND Angiogenesis
Previous Study | Return to List | Next Study

Efficacy Study of Revlimid® and Low Dose Continuously Administered Melphalan to Treat High Risk MDS (REMMYDYS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00744536
Recruitment Status : Completed
First Posted : September 1, 2008
Last Update Posted : June 9, 2017
Sponsor:
Collaborator:
Celgene
Information provided by (Responsible Party):
Dr. Rena Buckstein, Sunnybrook Health Sciences Centre

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 2012
Actual Study Completion Date : December 2012